Visiomed shares, whose trading was suspended on Friday, gained over 20% this morning in Paris.

As a reminder, the group had decided to suspend its share price at the end of the week in order to respond to accusations deemed 'unacceptable, misleading and defamatory' published by BewellConnect on August 18 on the LinkedIn social network.

Visiomed also refers to 'a second aberrant message' with 'conspiracy overtones' published by BewellConnect's External CFO.

The group states that its share price has been severely destabilized, with a fall of almost 30% in less than 5 hours and more than 38 million euros in lost shareholder value.

Visiomed considers that it has been the victim of 'outright blackmail' by BewellConnect, since the press release, considered outrageous, was issued after Visiomed had refused to respond favorably to a financing request from Bewellthy and Medsco Invest.

BewellConnect is a structure 100% owned by Bewellthy (a holding company controlled by Medsco Invest), of which Visiomed is a minority shareholder.

Visiomed, which asserts that its 2022 accounts have been validated without reservation and that all agreements relating to Bewellthy have always been respected, indicates that it has instructed its advisors to alert the Autorité des Marchés Financiers and to file a complaint 'for defamation and dissemination of inaccurate and misleading information'.

Copyright (c) 2023 CercleFinance.com. All rights reserved.